A citation-based method for searching scientific literature

Jens M Teodoridis, Jacqueline Hall, Sharon Marsh, Hilary D Kannall, Catriona Smyth, Jorge Curto, Nadeem Siddiqui, Hani Gabra, Howard L McLeod, Gordon Strathdee, Robert Brown. Cancer Res 2005
Times Cited: 186







List of co-cited articles
1041 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients.
Inmaculada Ibanez de Caceres, Cristina Battagli, Manel Esteller, James G Herman, Essel Dulaimi, Mitchell I Edelson, Cynthia Bergman, Hormoz Ehya, Burton L Eisenberg, Paul Cairns. Cancer Res 2004
189
24

DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.
Caroline A Barton, Neville F Hacker, Susan J Clark, Philippa M O'Brien. Gynecol Oncol 2008
132
20


Promoter hypermethylation profile of ovarian epithelial neoplasms.
Prakash B Makarla, M Hossein Saboorian, Raheela Ashfaq, Kiyomi O Toyooka, Shinichi Toyooka, John D Minna, Adi F Gazdar, John O Schorge. Clin Cancer Res 2005
109
19

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
Toshiyasu Taniguchi, Marc Tischkowitz, Najim Ameziane, Shirley V Hodgson, Christopher G Mathew, Hans Joenje, Samuel C Mok, Alan D D'Andrea. Nat Med 2003
414
18

The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients.
Gillian Gifford, Jim Paul, Paul A Vasey, Stanley B Kaye, Robert Brown. Clin Cancer Res 2004
189
17

The fundamental role of epigenetic events in cancer.
Peter A Jones, Stephen B Baylin. Nat Rev Genet 2002
16

Prognostic DNA methylation biomarkers in ovarian cancer.
Susan H Wei, Curtis Balch, Henry H Paik, Yoo-Sung Kim, Rae Lynn Baldwin, Sandya Liyanarachchi, Lang Li, Zailong Wang, Joseph C Wan, Ramana V Davuluri,[...]. Clin Cancer Res 2006
109
16

The epigenomics of cancer.
Peter A Jones, Stephen B Baylin. Cell 2007
15

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
R L Baldwin, E Nemeth, H Tran, H Shvartsman, I Cass, S Narod, B Y Karlan. Cancer Res 2000
247
14

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.
Grant C Sellar, Karen P Watt, Genevieve J Rabiasz, Euan A Stronach, Li Li, Eric P Miller, Charles E Massie, Jayne Miller, Bruno Contreras-Moreira, Diane Scott,[...]. Nat Genet 2003
140
14

Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes.
G Strathdee, K Appleton, M Illand, D W Millan, J Sargent, J Paul, R Brown. Am J Pathol 2001
159
14

Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.
Wei Dai, Jens M Teodoridis, Constanze Zeller, Janet Graham, Jenny Hersey, James M Flanagan, Euan Stronach, David W Millan, Nadeem Siddiqui, Jim Paul,[...]. Clin Cancer Res 2011
69
20

Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.
Asha Rathi, Arvind K Virmani, John O Schorge, Keren J Elias, Riichiroh Maruyama, John D Minna, Samuel C Mok, Luc Girard, David A Fishman, Adi F Gazdar. Clin Cancer Res 2002
102
13

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
12

Inactivation of BRCA1 and BRCA2 in ovarian cancer.
Jeffrey L Hilton, John P Geisler, Jennifer A Rathe, Melanie A Hattermann-Zogg, Barry DeYoung, Richard E Buller. J Natl Cancer Inst 2002
162
12

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.
Andrew Wiley, Dionyssios Katsaros, Haigang Chen, Irene A Rigault de la Longrais, Alicia Beeghly, Manuela Puopolo, Rakesh Singal, Yan Zhang, Agyenim Amoako, Daniel Zelterman,[...]. Cancer 2006
84
14

Gene silencing in cancer in association with promoter hypermethylation.
James G Herman, Stephen B Baylin. N Engl J Med 2003
11

Epigenetics in cancer.
Manel Esteller. N Engl J Med 2008
11

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
M Esteller, J M Silva, G Dominguez, F Bonilla, X Matias-Guiu, E Lerma, E Bussaglia, J Prat, I C Harkes, E A Repasky,[...]. J Natl Cancer Inst 2000
807
11


Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.
Susan H Wei, Chuan-Mu Chen, Gordon Strathdee, Jaturon Harnsomburana, Chi-Ren Shyu, Farahnaz Rahmatpanah, Huidong Shi, Shu-Wing Ng, Pearlly S Yan, Kenneth P Nephew,[...]. Clin Cancer Res 2002
152
10

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.
Fang Fang, Curt Balch, Jeanne Schilder, Timothy Breen, Shu Zhang, Changyu Shen, Lang Li, Carol Kulesavage, Anthony J Snyder, Kenneth P Nephew,[...]. Cancer 2010
113
10

Hallmarks of 'BRCAness' in sporadic cancers.
Nicholas Turner, Andrew Tutt, Alan Ashworth. Nat Rev Cancer 2004
10

Resistance to therapy caused by intragenic deletion in BRCA2.
Stacey L Edwards, Rachel Brough, Christopher J Lord, Rachael Natrajan, Radost Vatcheva, Douglas A Levine, Jeff Boyd, Jorge S Reis-Filho, Alan Ashworth. Nature 2008
656
10


DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
Sahar Houshdaran, Sarah Hawley, Chana Palmer, Mihaela Campan, Mari N Olsen, Aviva P Ventura, Beatrice S Knudsen, Charles W Drescher, Nicole D Urban, Patrick O Brown,[...]. PLoS One 2010
72
13

Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.
Her-Young Su, Hung-Cheng Lai, Ya-Wen Lin, Chin-Yun Liu, Chi-Kuan Chen, Yu-Ching Chou, Shin-Ping Lin, Wen-Chi Lin, Hsin-Yi Lee, Mu-Hsien Yu. Int J Cancer 2010
120
10

Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.
J Staub, J Chien, Y Pan, X Qian, K Narita, G Aletti, M Scheerer, L R Roberts, J Molina, V Shridhar. Oncogene 2007
83
12

DNA hypomethylation and ovarian cancer biology.
Martin Widschwendter, Guanchao Jiang, Christian Woods, Hannes M Müller, Heidi Fiegl, Georg Goebel, Christian Marth, Elisabeth Müller-Holzner, Alain G Zeimet, Peter W Laird,[...]. Cancer Res 2004
165
9

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer.
Meng Li, Curt Balch, John S Montgomery, Mikyoung Jeong, Jae Hoon Chung, Pearlly Yan, Tim H M Huang, Sun Kim, Kenneth P Nephew. BMC Med Genomics 2009
158
9

DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.
Qinghua Wu, Ragnhild A Lothe, Terje Ahlquist, Ilvars Silins, Claes G Tropé, Francesca Micci, Jahn M Nesland, Zhenhe Suo, Guro E Lind. Mol Cancer 2007
104
9

Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors.
Thomas E Liggett, Anatoliy Melnikov, Qilong Yi, Charles Replogle, Wei Hu, Jacob Rotmensch, Aparna Kamat, Anil K Sood, Victor Levenson. Gynecol Oncol 2011
65
13

An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.
Her-Young Su, Hung-Cheng Lai, Ya-Wen Lin, Yu-Ching Chou, Chin-Yu Liu, Mu-Hsien Yu. Int J Cancer 2009
107
9

Ovarian cancer: strategies for overcoming resistance to chemotherapy.
Roshan Agarwal, Stan B Kaye. Nat Rev Cancer 2003
809
9

HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer.
Heidi Fiegl, Gudrun Windbichler, Elisabeth Mueller-Holzner, Georg Goebel, Matthias Lechner, Ian J Jacobs, Martin Widschwendter. Int J Cancer 2008
80
11

Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer.
Céline Montavon, Brian S Gloss, Kristina Warton, Caroline A Barton, Aaron L Statham, James P Scurry, Bruce Tabor, Tuan V Nguyen, Wenja Qu, Goli Samimi,[...]. Gynecol Oncol 2012
74
12

Whole-genome characterization of chemoresistant ovarian cancer.
Ann-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, Dale W Garsed, Joshy George, Sian Fereday, Katia Nones, Prue Cowin, Kathryn Alsop, Peter J Bailey,[...]. Nature 2015
740
9

Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades.
Jill S Barnholtz-Sloan, Ann G Schwartz, Faisal Qureshi, Suzanne Jacques, John Malone, Adnan R Munkarah. Am J Obstet Gynecol 2003
143
8


Epigenetics as a mechanism driving polygenic clinical drug resistance.
R M Glasspool, J M Teodoridis, R Brown. Br J Cancer 2006
173
8

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
8

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer.
Siqing Fu, Wei Hu, Revathy Iyer, John J Kavanagh, Robert L Coleman, Charles F Levenback, Anil K Sood, Judith K Wolf, David M Gershenson, Maurie Markman,[...]. Cancer 2011
109
8

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
J G Herman, J R Graff, S Myöhänen, B D Nelkin, S B Baylin. Proc Natl Acad Sci U S A 1996
8

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
8

Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
Panagiotis A Konstantinopoulos, Dimitrios Spentzos, Beth Y Karlan, Toshiyasu Taniguchi, Elena Fountzilas, Nancy Francoeur, Douglas A Levine, Stephen A Cannistra. J Clin Oncol 2010
321
8


Methylation profile in benign, borderline and malignant ovarian tumors.
K F Tam, V W S Liu, S S Liu, P C K Tsang, A N Y Cheung, A M W Yip, H Y S Ngan. J Cancer Res Clin Oncol 2007
42
19

Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.
Hui-Juan Yang, Vincent W S Liu, Yue Wang, Percy C K Tsang, Hextan Y S Ngan. BMC Cancer 2006
121
8

Minireview: epigenetic changes in ovarian cancer.
Curt Balch, Fang Fang, Daniela E Matei, Tim H-M Huang, Kenneth P Nephew. Endocrinology 2009
108
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.